New Treatment Kills Metastatic Cancer Cells
robert2cane points out a promising study from Cornell University about controlling the spread of cancer. There are many treatments for an isolated tumor, but once cancer cells reach the bloodstream and start spreading through the body, it's much more difficult to control. The new research (PDF), led by Michael King, developed a compound that is able to target and eliminate cancer cells in the blood of mice.
"When attempting to develop a treatment for metastases, King faced two problems: targeting moving cancer cells and ensuring cell death could be activated once they were located. To handle both issues, he built fat-based nanoparticles that were one thousand times smaller than a human hair and attached two proteins to them. One is E-selectin, which selectively binds to white blood cells, and the other is TRAIL. He chose to stick the nanoparticles to white blood cells because it would keep the body from excreting them easily. This means the nanoparticles, made from fat molecules, remain in the blood longer and thus have a greater chance of bumping into freely moving cancer cells. There is an added advantage. Red blood cells tend to travel in the center of a blood vessel, and white blood cells stick to the edges. This is because red blood cells are lower density and can be easily deformed to slide around obstacles. Cancer cells have a similar density to white blood cells and remain close to the walls, too. As a result, these nanoparticles are more likely to bump into cancer cells and bind their TRAIL receptors."
"New treatment kills some but not all metastatic cancer cells in mice, but only while they're traversing the bloodstream and so far only when the cells are injected into the mice in the first place".
Trust the Computer. The Computer is your friend.
What would set this research apart is it's ability to kill metastasizing cancer.
It is not a useless advancement, but it apparently needs to also kill cancer present in distant organs to be of significant impact.
Happiness in intelligent people is the rarest thing I know.
Ernest Hemingway
Physicist Lowell Wood in a brainstorming meeting: a question for everyone. You have a tumor, and the tumor becomes metastatic, and it sheds metastatic cancer cells. How long do those circulate in the bloodstream before they land?’ And we all said, ‘We don’t know. Ten times?’ ‘No,’ he said. ‘As many as a million times.’ Isn’t that amazing? If you had no time, you’d be screwed. But it turns out that these cells are in your blood for as long as a year before they land somewhere. What that says is that you’ve got a chance to intercept them.”
How did Wood come to this conclusion? He had run across a stray fact in a recent issue of The New England Journal of Medicine. “It was an article that talked about, at one point, the number of cancer cells per millilitre of blood,” he said. “And I looked at that figure and said, ‘Something’s wrong here. That can’t possibly be true.’ The number was incredibly high. Too high. It has to be one cell in a hundred litres, not what they were saying—one cell in a millilitre. Yet they spoke of it so confidently. I clicked through to the references. It was a commonplace. There really were that many cancer cells.”
Wood did some arithmetic. He knew that human beings have only about five litres of blood. He knew that the heart pumps close to a hundred millilitres of blood per beat, which means that all of our blood circulates through our bloodstream in a matter of minutes. The New England Journal article was about metastatic breast cancer, and it seemed to Wood that when women die of metastatic breast cancer they don’t die with thousands of tumors. The vast majority of circulating cancer cells don’t do anything.
“It turns out that some small per cent of tumor cells are actually the deadly ones,” he went on. “Tumor stem cells are what really initiate metastases. And isn’t it astonishing that they have to turn over at least ten thousand times before they can find a happy home? You naïvely think it’s once or twice or three times. Maybe five times at most. It isn’t. In other words, metastatic cancer—the brand of cancer that kills us—is an amazingly hard thing to initiate. Which strongly suggests that if you tip things just a little bit you essentially turn off the process.”
Forgot to attribute the above to the New Yorker Magazine (http://www.newyorker.com/reporting/2008/05/12/080512fa_fact_gladwell/?currentPage=all)
What do you say, lets start a campaign to get the standards and measures people to make human hair an actual measurement standard.
It all starts at 0
Comment removed based on user account deletion
Here is the actual article in Nature (because the linked story doesn't actually provide it):
http://www.nature.com/nature/journal/v483/n7391/full/483531a.html
Would it be possible to replace or filter a patient's blood after excision of the tumor?
If this is the case, then cancer diagnostic exams should remove these cells from your blood stream, firstly.
Secondly, if you require surgery or treatment, cells in your blood stream after removal of the primary cancer should then be removed.
Which makes a lot of sense, because cancer sometimes comes back to reinfect the patient.
So this would suggest, that part of the protocols for cancer treatment would require the patient to undego some sort of immuno therapy for blood work to complete the treatment.
-Hack
Got Geometrodynamics? Awe, too hard to figure out? Too bad.